ISPE And FDC-Windhover Team Up To Offer PharmAsia News

Main Category: Pharma Industry / Biotech Industry
Article Date: 18 Nov 2008 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, and FDC-Windhover announced today that the two organizations have teamed up to provide discounted subscriptions of PharmAsia News to ISPE Members, as well as complimentary access to monthly articles.

"As the Asian pharmaceutical industry continues to grow, PharmaAsia News will be a valuable resource for our Members as they work, serve, and network with their pharmaceutical industry counterparts," said Robert P. Best, ISPE's President and CEO.

Leveraging the high editorial quality of FDC Reports' The Pink Sheet, PharmAsia News provides information regarding the regulatory, legal, and financial developments affecting pharmaceutical, biologics, and medical device manufacturers doing business in China, India, Japan, and the Pacific Rim.

The first complimentary article being offered is entitled GSK Managing Director Hasit Joshipura On What Lies Ahead for India's Largest Multinational Drug Company: An Interview with PharmAsia News. Once downloading the article, ISPE Members will receive a certificate for a one-year discounted subscription to PharmAsia News.

Visit http://offers.fdcreports.com/ISPER/ to access a complimentary article from PharmAsia News and for more information about a discounted subscription for ISPE Members.

About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 25,000 pharmaceutical science and manufacturing professionals in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; its Asia Pacific office in Singapore; and its newly established office in Shanghai, China.. Visit www.ISPE.org for additional Society news and information.

About PharmAsia News

PharmAsia News covers regulatory, legal, and financial developments affecting pharmaceutical, biologics, and medical device manufacturers doing business in China, India, Japan, and the Pacific Rim. News bureaus across Asia provide around-the-clock coverage on the web and twice-weekly e-mail newsletters to help readers stay on top of these rapidly developing markets. PharmAsiaNews leverages the editorial excellence of "The Pink Sheet," the leading information source for the U.S. pharmaceutical industry since 1939. http://www.pharmasianews.com

Source
Elizabeth Pierre-Saint
Communications Coordinator, ISPE
3109 W. Dr. Martin Luther King Jr. Blvd.
Tampa, FL 33607
http://www.ISPE.org
ISPE - Engineering Pharmaceutical Innovation

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
ISPE. "ISPE And FDC-Windhover Team Up To Offer PharmAsia News." Medical News Today. MediLexicon, Intl., 18 Nov. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/129788.php>

APA
ISPE. (2008, November 18). "ISPE And FDC-Windhover Team Up To Offer PharmAsia News." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/129788.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »